We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
Cap. Flow
+$29.6M
Cap. Flow %
3.15%
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215

Top Buys

Rank Stock Value
1
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$5.37M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$3.7M
3
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$2.54M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$2.12M
5
NVDA icon
NVIDIA
NVDA
+$1.88M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.88M
2
XLP icon
State Street Consumer Staples Select Sector SPDR ETF
XLP
+$4.62M
3
OCSL icon
Oaktree Specialty Lending
OCSL
+$825K
4
MGI
MoneyGram International, Inc. New
MGI
+$627K
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$562K

Sector Composition

Rank Sector Weight
1 Financials 16.18%
2 Technology 15.3%
3 Healthcare 6.27%
4 Consumer Discretionary 3.61%
5 Industrials 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACRS icon
2576
Aclaris Therapeutics
ACRS
$869M
$353 ﹤0.01%
+34
New +$308
NEXT icon
2577
NextDecade
NEXT
$1.78B
$353 ﹤0.01%
+43
New +$264
SCHH icon
2578
Schwab US REIT ETF
SCHH
$11.4B
$352 ﹤0.01%
18
– –
NETI
2579
DELISTED
Eneti Inc.
NETI
$351 ﹤0.01%
29
-142
-83% -$1.39K
CDMO
2580
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$349 ﹤0.01%
+25
New +$426
PLMR icon
2581
Palomar
PLMR
$3.45B
$348 ﹤0.01%
6
-27
-82% -$1.44K
VCTR icon
2582
Victory Capital Holdings
VCTR
$6.65B
$347 ﹤0.01%
11
-53
-83% -$1.64K
MTUS icon
2583
Metallus
MTUS
$898M
$345 ﹤0.01%
+16
New +$290
SRDX
2584
DELISTED
Surmodics
SRDX
$344 ﹤0.01%
11
+4
+57% +$91
MTRN icon
2585
Materion
MTRN
$6.04B
$343 ﹤0.01%
3
– –
JMIA
2586
Jumia Technologies
JMIA
$767M
$342 ﹤0.01%
100
– –
TFII icon
2587
TFI International
TFII
$11.5B
$342 ﹤0.01%
3
-14
-82% -$1.54K
PECO icon
2588
Phillips Edison & Co
PECO
$5.24B
$341 ﹤0.01%
+10
New +$312
PHR icon
2589
Phreesia
PHR
$773M
$341 ﹤0.01%
11
– –
WOW
2590
DELISTED
WideOpenWest
WOW
$338 ﹤0.01%
40
-123
-75% -$1.11K
EVGO icon
2591
EVgo
EVGO
$229M
$336 ﹤0.01%
84
– –
SAH icon
2592
Sonic Automotive
SAH
$2.61B
$334 ﹤0.01%
+7
New +$323
TRTX
2593
TPG RE Finance Trust
TRTX
$618M
$333 ﹤0.01%
+45
New +$305
CENX icon
2594
Century Aluminum
CENX
$5.07B
$331 ﹤0.01%
38
– –
CVEO icon
2595
Civeo
CVEO
$318M
$331 ﹤0.01%
17
– –
ASO icon
2596
Academy Sports + Outdoors
ASO
$2.98B
$324 ﹤0.01%
6
-4
-40% -$230
MX icon
2597
Magnachip Semiconductor
MX
$145M
$324 ﹤0.01%
+29
New +$284
SIBN icon
2598
SI-BONE Inc
SIBN
$834M
$324 ﹤0.01%
+12
New +$293
BRSP
2599
BrightSpire Capital
BRSP
$648M
$323 ﹤0.01%
48
-70
-59% -$415
BWIN
2600
Baldwin Insurance Group
BWIN
$2.86B
$322 ﹤0.01%
+13
New +$308
102 103
104
105 106

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.

  • Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
  • Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
  • Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
  • Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
  • Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
  • Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
  • Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.

Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.